Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma

Publication ,  Conference
Martin, T; Richter, J; Vij, R; Cole, C; Atanackovic, D; Zonder, J; Kaufman, JL; Bensinger, W; Dimopoulos, MA; San Miguel, J; Zimmerman, T ...
Published in: BLOOD
December 3, 2015

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 3, 2015

Volume

126

Issue

23

Location

Orlando, FL

Publisher

AMER SOC HEMATOLOGY

Conference Name

57th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Martin, T., Richter, J., Vij, R., Cole, C., Atanackovic, D., Zonder, J., … Mikhael, J. (2015). A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma. In BLOOD (Vol. 126). Orlando, FL: AMER SOC HEMATOLOGY.
Martin, Thomas, Joshua Richter, Ravi Vij, Craig Cole, Djordje Atanackovic, Jeffrey Zonder, Jonathan L. Kaufman, et al. “A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma.” In BLOOD, Vol. 126. AMER SOC HEMATOLOGY, 2015.
Martin T, Richter J, Vij R, Cole C, Atanackovic D, Zonder J, et al. A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma. In: BLOOD. AMER SOC HEMATOLOGY; 2015.
Martin T, Richter J, Vij R, Cole C, Atanackovic D, Zonder J, Kaufman JL, Bensinger W, Dimopoulos MA, San Miguel J, Zimmerman T, Lendvai N, Hari P, Ocio EM, Gasparetto C, Kumar S, Hsu K, Charpentier E, Strickland SA, Mikhael J. A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma. BLOOD. AMER SOC HEMATOLOGY; 2015.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 3, 2015

Volume

126

Issue

23

Location

Orlando, FL

Publisher

AMER SOC HEMATOLOGY

Conference Name

57th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology